Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching frail elderly atrial fibrillation patients from VKA to NOAC
NL-OMON55760Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dabigatran, rivaroxaban, apixaban, edoxaban, acenocoumarol and 1 more in Atrial fibrillation (AFib) (2 arms), sponsored by University Medical Center Utrecht. Started Jan 2018; status: recruiting.
02
Drugs
dabigatranrivaroxabanapixabanedoxabanacenocoumarol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON55760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55760.